Advances in Influenza Virus and Therapy

Influenza, commonly known as “the flu”, is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include: a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. Complications of influenza may include viral pneumonia, secondary bacterial pneumonia, sinus infections, and worsening of previous health problems such as asthma or heart failure. People with the flu are advised to get plenty of rest, drink plenty of liquids, avoid using alcohol and tobacco and, if necessary, take medications such as acetaminophen (paracetamol) to relieve the fever and muscle aches associated with the flu. Since influenza is caused by a virus, antibiotics have no effect on the infection; unless prescribed for secondary infections such as bacterial pneumonia. Antiviral medication may be effective, if given early, but some strains of influenza can show resistance to the standard antiviral drugs and there is concern about the quality of the research.


In the present book, fourteen typical literatures about influenza virus and therapy published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, virus disease, virology, epidemiology, ect. We hope this book can demonstrate advances in influenza virus and therapy as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    An Analysis of Microbiota-Targeted Therapies in Patients with Avian Influenza Virus Subtype H7N9 Infection
  • Chapter 2
    Chronic Spinal Cord Injury Attenuates Influenza Virus-Specific Antiviral Immunity
  • Chapter 3
    A Computational Method for Predicting Regulation of Human MicroRNAs on the Influenza Virus Genome
  • Chapter 4
    Characterisation of a Wild-Type Influenza (A/H1N1) Virus Strain as an Experimental Challenge Agent in Humans
  • Chapter 5
    Lung Epithelial GM-CSF Improves Host Defense Function and Epithelial Repair in Influenza Virus Pneumonia—A New Therapeutic Strategy?
  • Chapter 6
    Protective Immunity against Influenza H5N1 Virus Challenge in Chickens by Oral Administration of Recombinant Lactococcus Lactis Expressing Neuraminidase
  • Chapter 7
    Intranasal Administration of Poly-Gamma Glutamate Induced Antiviral Activity and Protective Immune Responses against H1N1 Influenza a Virus Infection
  • Chapter 8
    Influenza Virus Infection Is Associated with Increased Risk of Death amongst Patients Hospitalized with Confirmed Pulmonary Tuberculosis in South Africa, 2010–2011
  • Chapter 9
    Quantifying the Therapeutic Requirements and Potential for Combination Therapy to Prevent Bacterial Coinfection during Influenza
  • Chapter 10
    Relationship of Influenza Virus Infection to Associated Infections in Children Who Present with Influenza-Like Symptoms
  • Chapter 11
    3-Anhydro-6-Hydroxy-Ophiobolin a Displays High in Vitro and in Vivo Efficacy against Influenza a Virus Infection
  • Chapter 12
    Nosocomial Outbreak of the Pandemic Influenza A (H1N1) 2009 in Critical Hematologic Patients during Seasonal Influenza 2010-2011: Detection of Oseltamivir Resistant Variant Viruses
  • Chapter 13
    Pulmonary Immune Responses to 2009 Pandemic Influenza A (H1N1) Virus in Mice
  • Chapter 14
    Gene Silencing of β-Galactosamide α-2,6-Sialyltransferase 1 Inhibits Human Influenza Virus Infection of Airway Epithelial Cells
Readership: Students, academics, teachers and other people attending or interested in Influenza Virus and Therapy.
Samita Andreansky, The Miami Project to Cure Paralysis, Department of Neurosurgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA

James N. Francis, Immune Targeting Systems Ltd, London BioScience Innovation Centre, 2 Royal College Street, London NW1 0NH, UK

Barbara Rösler, Dr von Hauner Children’s Hospital, Ludwig Maximilians University, Lindwurmstrasse 4, 80337 Munich, Germany

Han Lei, Department of Biomedical Engineering, State University of New York, Binghamton 13902, USA

Haryoung Poo, Viral Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea

Amber M. Smith, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA

and more...
This Book

338pp. Published December 2016

Scientific Research Publishing, Inc.,USA.

Category:Biomedical & Life Sciences

ISBN: 978-1-61896-296-6

(Hardcover) USD 109.00

ISBN: 978-1-61896-295-9

(Paperback) USD 89.00

Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org
Follow SCIRP
Contact us
book@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1243940697
Book Publishing WeChat
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top